// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "MERCHANTABILITY NOT data file organism individual DIA II OPTIONAL PMCID PTM AC spiked compound biological replicate INFORMATION NCBI PROTEOMICS EW XL THE ZFA HF instrument label HUPO SHALL INITIATIVE MOD MIAME DOID BE MAGE RIGHTS FITNESS PO FOR DTT CF file your CID IMPORTANT QY BMC EM BTO HTML MINOR TA CT TIP MANDATORY RFC ID age CL SDRF PATCH WARRANTIES LI CN ANY reduction reagent EXPRESS UBERON PSI ISA PP MONDO MT REQUIRES TMT characteristics cleavage agent details CS biosample accession number INCLUDING fractionation method SWATH mass CPTAC README SN PRM SP EFO FDR LIMITED DJ BUT VCF ENVO developmental stage IMPLIED cell type STANDARDS disease stage VK NT LC JA REQUIRED ancestry category collision energy PRIDE technical replicate MAY CELL pooled sample COULD BRENDA SHOULD MC THAT OF TO DDA EBI PS PRIDE:0000659 WARRANTY INFRINGE MS HCD MAJOR SH OR SILAC sex fraction identifier alkylation reagent COLUMN MHC RECOMMENDED dissociation method MUST PEPTIDESEQ NCE WILL IDF PATO disease proteomics data acquisition method DISCLAIMS sample PMID organism part source name_ and _assay name ROW CV RECOMMEND RAW replicate NOTE MS:1001251 URL URI AS ... USE HEREIN IS CLO ALL TAB PARTICULAR exclamation source name HANCESTRO depletion XML IAA PURPOSE SRM III"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-08-13\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often ",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "MERCHANTABILITY NOT data file organism individual DIA II OPTIONAL PMCID PTM AC spiked compound biological replicate INFORMATION NCBI PROTEOMICS EW XL THE ZFA HF instrument label HUPO SHALL INITIATIVE MOD MIAME DOID BE MAGE RIGHTS FITNESS PO FOR DTT CF CID QY BMC EM BTO HTML MINOR TA CT MANDATORY RFC age CL SDRF PATCH WARRANTIES LI CN ANY reduction reagent EXPRESS UBERON PSI ISA PP MONDO MT REQUIRES TMT cleavage agent details CS biosample accession number INCLUDING fractionation method SWATH mass CPTAC README SN PRM SP EFO FDR LIMITED DJ BUT VCF ENVO IMPLIED cell type STANDARDS disease stage VK NT LC JA REQUIRED ancestry category collision energy PRIDE technical replicate MAY CELL pooled sample COULD BRENDA SHOULD MC THAT OF TO DDA EBI PS PRIDE:0000659 WARRANTY INFRINGE MS HCD MAJOR SH OR SILAC sex fraction identifier alkylation reagent COLUMN MHC RECOMMENDED dissociation method MUST PEPTIDESEQ NCE WILL IDF PATO disease proteomics data acquisition method DISCLAIMS PMID organism part ROW CV RECOMMEND RAW URL MS:1001251 AS URI ... USE HEREIN IS CLO ALL TAB PARTICULAR HANCESTRO depletion IAA PURPOSE SRM III"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html",
    "section": "Sample Metadata Convention",
    "keywords": "compound organism individual UBERON:0001359 disease model PTM CL:0000898 CSF UBERON:0002107 COVID MONDO:0005180 biological replicate UBERON:0001088 CL:0000233 MONDO:0004975 UBERON:0002048 UBERON:0000178 NCBI CL:0000236 DOID CL:0000084 CL:0000815 PO xenograft IMPORTANT CL:0000232 PATO:0001340 TIP age ID synthetic peptide lib MONDO:0005301 CL SDRF CL:0000057 UBERON MONDO:0008383 MONDO MONDO:0005575 MONDO:0100096 MONDO:0004946 CL:0000540 EFO MONDO:0005138 UBERON:0001969 UBERON:0000955 developmental stage cell type UBERON:0001977 ancestry category MONDO:0004989 NSG CL:0000788 MAY UBERON:0002113 MONDO:0005105 CL:0000787 SHOULD CL:0000235 UBERON:0000310 sex APP CL:0000623 CL:0000625 PATO:0000384 CML CL:0000451 PDX CL:0000182 MUST CL:0000624 CL:0000576 enrichment process PATO disease UBERON:0002097 organism part PATO:0000383 URL NOTE UBERON:0000948 CL:0000913 MONDO:0005148 DSS CL:0000066 ALL source name exclamation HANCESTRO depletion NK CL:0000813 UBERON:0001155 PATO:0000461"
  },
  {
    "title": "Sample Metadata Conventions",
    "content": "Sample Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These conventions apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata conventions define standardized formats for common properties that apply across all organism types. This convention covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Convention.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSk",
    "url": "./conventions/sample-metadata.html#sample-metadata-conventions",
    "section": "Sample Metadata Convention",
    "keywords": "compound organism individual UBERON:0001359 disease model PTM CL:0000898 CSF UBERON:0002107 COVID MONDO:0005180 biological replicate UBERON:0001088 CL:0000233 MONDO:0004975 UBERON:0002048 UBERON:0000178 NCBI CL:0000236 DOID CL:0000084 CL:0000815 PO xenograft CL:0000232 PATO:0001340 age ID synthetic peptide MONDO:0005301 CL SDRF CL:0000057 UBERON MONDO:0008383 MONDO MONDO:0005575 MONDO:0100096 MONDO:0004946 CL:0000540 EFO MONDO:0005138 UBERON:0001969 UBERON:0000955 developmental stage cell type UBERON:0001977 ancestry category MONDO:0004989 NSG CL:0000788 MAY UBERON:0002113 MONDO:0005105 CL:0000787 SHOULD CL:0000235 UBERON:0000310 sex APP CL:0000623 CL:0000625 PATO:0000384 CML CL:0000451 PDX CL:0000182 MUST CL:0000624 CL:0000576 enrichment process PATO disease UBERON:0002097 organism part PATO:0000383 URL UBERON:0000948 CL:0000913 MONDO:0005148 DSS CL:0000066 ALL source name HANCESTRO depletion NK CL:0000813 UBERON:0001155 PATO:0000461"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html",
    "section": "Human Metadata Convention",
    "keywords": "NCIT:C18213 NCIT:C28054 compound weight organism individual NCIT prior treatment II MONDO:0005300 HANCESTRO:0005 NCIT:C28078 ethnicity diet PR BMI CHEBI:6801 Dukes stage NCIT:C71732 tumor grade GDPR NCIT:C65106 TNM staging NCIT:C18058 pre-existing condition NCIT:C14167 NCIT:C53553 IMPORTANT NCI NCIT:C18206 age ID NCIT:C14169 SDRF secondary condition NCIT:C15262 TNM HANCESTRO:0010 CHEBI:27899 NCIT:C14168 breast cancer subtype MONDO NCIT:C65107 time post treatment treatment response ER AJCC HIPAA HANCESTRO:0009 NCIT:C62723 UO EFO HANCESTRO:0006 MONDO:0005044 gestational age disease stage NCIT:C4870 NCIT:C68804 IV NCIT:C81327 medication history ancestry category treatment status NCIT:C27966 smoking status NCIT:C27970 NCIT:C16358 dose PREFERRED NCIT:C28077 NCIT:C15329 sampling time point MONDO:0002050 Ann Arbor stage NCIT:C28076 height NCIT:C14174 treatment menopausal status NCIT:C28079 sex pregnancy status NCIT:C53555 NCIT:C81328 NCIT:C53554 NCIT:C27971 body mass index ACE disease CHEBI:28748 MONDO:0011122 organism part MONDO:0004995 NOTE NCIT:C53556 NCIT:C15313 MONDO:0005148 MONDO:0004979 NCIT:C65108 NCIT:C15445 alcohol consumption PD NCIT:C15632 exclamation CHEBI:41774 HANCESTRO III"
  },
  {
    "title": "Human Sample Metadata Convention",
    "content": "Human Sample Metadata Convention\n\nStatus of this Convention\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These conventions apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This convention defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata conventions (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Conventions.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g",
    "url": "./conventions/human-metadata.html#human-sample-metadata-convention",
    "section": "Human Metadata Convention",
    "keywords": "NCIT:C18213 NCIT:C28054 compound weight organism individual NCIT prior treatment II MONDO:0005300 HANCESTRO:0005 NCIT:C28078 ethnicity diet PR BMI CHEBI:6801 Dukes stage NCIT:C71732 tumor grade GDPR NCIT:C65106 TNM staging NCIT:C18058 pre-existing condition NCIT:C14167 NCIT:C53553 NCI NCIT:C18206 age ID NCIT:C14169 SDRF secondary condition NCIT:C15262 TNM HANCESTRO:0010 CHEBI:27899 NCIT:C14168 breast cancer subtype MONDO NCIT:C65107 time post treatment treatment response ER AJCC HIPAA HANCESTRO:0009 NCIT:C62723 UO EFO HANCESTRO:0006 MONDO:0005044 gestational age disease stage NCIT:C4870 NCIT:C68804 IV NCIT:C81327 medication history ancestry category treatment status NCIT:C27966 smoking status NCIT:C27970 NCIT:C16358 dose PREFERRED NCIT:C28077 NCIT:C15329 sampling time point MONDO:0002050 Ann Arbor stage NCIT:C28076 height NCIT:C14174 treatment menopausal status NCIT:C28079 sex pregnancy status NCIT:C53555 NCIT:C81328 NCIT:C53554 NCIT:C27971 body mass index ACE disease CHEBI:28748 MONDO:0011122 organism part MONDO:0004995 NCIT:C53556 NCIT:C15313 MONDO:0005148 MONDO:0004979 NCIT:C65108 NCIT:C15445 alcohol consumption PD NCIT:C15632 CHEBI:41774 HANCESTRO III"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html",
    "section": "Data File Metadata Convention",
    "keywords": "MRM MS2 analyzer type UNIMOD:4 NT UNIMOD:35 scan window upper limit RECOMMENDED data file MS:1001313 REQUIRED SCIEX DIA modification parameters MS:1001917 MUST PRIDE TA TIP UNIMOD:21 technical replicate LTQ ID SDRF AC MM proteomics data acquisition method RPPA MGF PSI sample UNIMOD precursor mass tolerance PP SHOULD RAW FTP MT URL MS:1001251 TMT DDA URI NOTE XL CS cleavage agent details IMPORTANT HF ST label instrument MOD TS fragment mass tolerance PRM proteomexchange accession number KR UNIMOD:737 exclamation MS:1001309 MS ELISA MS:1001303 file uri MSD fraction TOF fraction identifier MS:1001306 SILAC scan window lower limit CF SRM MS1 scan range PRIDE:0000663 UNIMOD:1"
  },
  {
    "title": "Data File Metadata Conventions",
    "content": "Data File Metadata Conventions\n\nStatus of this Convention\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These conventions define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata conventions define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This convention covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata conventions (organism, age, sex, disease), see Sample Metadata Conventions.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\ns",
    "url": "./conventions/data-file-metadata.html#data-file-metadata-conventions",
    "section": "Data File Metadata Convention",
    "keywords": "MRM MS2 analyzer type UNIMOD:4 NT UNIMOD:35 scan window upper limit RECOMMENDED data file MS:1001313 REQUIRED SCIEX DIA modification parameters MS:1001917 MUST PRIDE TA UNIMOD:21 technical replicate LTQ ID SDRF AC MM proteomics data acquisition method RPPA MGF PSI UNIMOD precursor mass tolerance PP SHOULD RAW FTP MT URL MS:1001251 TMT DDA URI XL CS cleavage agent details HF ST label instrument MOD TS fragment mass tolerance PRM proteomexchange accession number KR UNIMOD:737 MS:1001309 MS ELISA MS:1001303 file uri MSD TOF fraction identifier MS:1001306 SILAC scan window lower limit CF SRM MS1 scan range PRIDE:0000663 UNIMOD:1"
  }
];
